Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
2.505
-0.035 (-1.38%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Mereo BioPharma Group Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-43.25-29.47-42.2217.23-223.4
Upgrade
Depreciation & Amortization
1.091.060.890.872.18
Upgrade
Loss (Gain) From Sale of Assets
----0.1514.84
Upgrade
Loss (Gain) From Sale of Investments
-----0.05
Upgrade
Stock-Based Compensation
7.394.924.774.472.13
Upgrade
Other Operating Activities
2.313.94-9.91-27.01170.26
Upgrade
Change in Accounts Receivable
----0.80.19
Upgrade
Change in Accounts Payable
0.15-1.260.62-1.7-4.85
Upgrade
Change in Other Net Operating Assets
-0.52-0.33-2.97--
Upgrade
Operating Cash Flow
-32.83-21.13-48.82-7.09-38.69
Upgrade
Capital Expenditures
---0.01-0.72-0.02
Upgrade
Cash Acquisitions
-----0.48
Upgrade
Sale (Purchase) of Intangibles
-0.7-0.4220.152.49
Upgrade
Other Investing Activities
---00.06
Upgrade
Investing Cash Flow
-0.7-0.421.99-0.572.04
Upgrade
Long-Term Debt Issued
----60.59
Upgrade
Long-Term Debt Repaid
--3.19--0.94-29.88
Upgrade
Net Debt Issued (Repaid)
--3.19--0.9430.7
Upgrade
Issuance of Common Stock
4711.61-106.427.49
Upgrade
Other Financing Activities
-0.85-0.440.2-0.32-10.77
Upgrade
Financing Cash Flow
46.157.970.2105.1547.43
Upgrade
Foreign Exchange Rate Adjustments
-0.232.82-12.58-1.58-1.05
Upgrade
Miscellaneous Cash Flow Adjustments
--0---
Upgrade
Net Cash Flow
12.38-10.76-59.2295.99.72
Upgrade
Free Cash Flow
-32.83-21.13-48.83-7.82-38.72
Upgrade
Free Cash Flow Margin
--211.32%--15.83%-
Upgrade
Free Cash Flow Per Share
-0.22-0.16-0.41-0.07-0.57
Upgrade
Cash Interest Paid
0.020.880.02-3.96
Upgrade
Cash Income Tax Paid
--1.341.88--
Upgrade
Levered Free Cash Flow
-21.5-14.17-32.74-9.08-25.67
Upgrade
Unlevered Free Cash Flow
-20.64-12.37-30.13-5.88-20.36
Upgrade
Change in Net Working Capital
-0.150.984.83-7.07-4.92
Upgrade
Updated Mar 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q